Find, organize, attend, and make the most of Oncology & Hematology events worldwide

OncoSystem Directory

Explore organizations in the global Oncology ecosystem

908 organization(s) found

Professional Association

EHA

The European Hematology Association (EHA) is the largest hematology community in Europe. A not-for-profit, membership-driven association based in the Netherlands. Effectively advocating for our members and the wider community at the highest level. Organizer of the annual EHA Congress, Europe’s largest hematology event.

The Hague, Netherlands
Website
University / R&D Center

EHESP (Ecole des hautes études en santé publique)

The EHESP is a public establishment with a dual role of education and research into public health and social welfare. It encourages synergy between the disparate cultures of public health and management. Four missions are conferred to EHESP by law: · to provide training for persons who have to exercise leadership, management, inspection or control functions in the health, social or medico-social fields; · to provide a network of higher education in public health; · to contribute to public health research activities; · to develop international relations, in particular through exchanges with institutions providing comparable teaching. The EHESP stands for the values of defending fundamental collective values around public service ethics, general interest, respect, openness and cooperation, continual improvement, and social and environmental responsibility.

Rennes, France
Public HealthTrainingEducationPublic Outreach
Website
Company

Eikon Therapeutics

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics through the purposeful integration of science and engineering.

Small-molecule drugs for Oncology and Neurosciences
Millbrae, CA, United States
Drug Discovery & DevelopmentSmall-Molecule DrugsPrecision OncologyInnate ImmunityTLR7/8Solid Tumors
Website
Hospital

EKCC - Addis Ababa (Else Kröner Center for Cancer Care)

The Else Kröner Center for Cancer Care (EKCC) project in Ethiopia is a comprehensive initiative aimed at enhancing and decentralizing cancer care in the country to reduce morbidity and mortality rates associated with breast and cervical cancer. With a budget of 2.5 million euros, the project lasts from February 2020 to January 2026. The project is being implemented by the Addis Ababa University School of Public Health in collaboration with the medical Faculty of Medicine at Martin Luther University Halle-Wittenberg.

Female Cancer Patient Care & Advocacy
Addis Ababa, Ethiopia
Cancer CarePatient CareEducationPublic HealthFemale CancersBreast CancerCervical Cancer
Website
Company

Ellipses Pharma

Ellipses Pharma develops new treatments for cancer that address unmet clinical need. We are focused exclusively on the development of innovative cancer medicines.

Small-Molecule Drugs, Biologics and ADCs for Oncology
London, United Kingdom
Drug Discovery & DevelopmentCancer TherapeuticsSmall-Molecule DrugsBiologicsConjugatesADCsSolid Tumors
Website
Patient Advocacy Group

ELLyE (Ensemble Leucémie Lymphomes Espoir)

French association of patients and relatives affected by lymphoma, chronic lymphocytic leukemia or Waldenström disease. Formerly France Lymphome Espoir.

Lymphoma and CLL Patient Support
Paris, France
HematologyBlood CancersLymphomaChronic Lymphocytic LeukemiaPatient Support
Website
Company

Elpiscience Biopharmaceuticals

Elpiscience has pioneered a globally leading pipeline of groundbreaking immunotherapies, focusing on critical targets to address the significant unmet clinical needs in oncology and autoimmune diseases.

Immunotherapies for Oncology and Autoimmune Diseases
Shanghai, China
Drug Development & DiscoveryCancer TherapeuticsImmunotherapyBiologicsBispecificsSolid Tumors
Website
Public Health / Government Agency

EMA (European Medicines Agency)

European Union agency in charge of the evaluation and supervision of medicines.

RegulatoryDrug ApprovalHealth Policy
Website
Hospital

Emory University Hospital

Atlanta, GA, United States
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Company

Ensoma

We are an in vivo hematopoietic stem cell (HSC) engineering company.

In vivo hematopoietic stem cells for Oncology and Genetic Diseases
Boston, MA, United States
Website
Professional Association

EORTC (European Organisation for Research and Treatment of Cancer)

Independent organisation that designs and runs academic cancer clinical trials across Europe.

Cancer Clinical Research
Brussels, Belgium
Clinical TrialsClinical ResearchOncology
Website
Company

Epigenic Therapeutics

Dedicated to developing next-generation gene modulation therapy utilizing regulation of the epigenetic genome for a variety of human diseases

Targeted epigenetic therapeutics via CRISPR-Cas components and LNPs across therapeutic areas
Shanghai, China
Drug Discovery & DevelopmentEpigenetic ModulationCancer TherapeuticsCRISPR-CASGene RegulationImmuno-OncologyCAR-T Therapy
Website
Company

Epitopea

We believe better cancer therapies are needed to transform people's lives. We are developing accessible off-the-shelf cancer RNA immunotherapies that will deliver durable benefits.

Shared neoantigen-based RNA vaccines for Oncology
Montréal, QC, Canada
Website
Hospital

Erasmus MC

Rotterdam, Netherlands
Patient CareClinical CareCancer CareCancer ResearchClinical OncologyClinical TrialsClinical Research
Website
Professional Association

ERIC (European Research Initiative on CLL)

European network of researchers and clinicians working on chronic lymphocytic leukemia.

Chronic Lymphocytic Leukemia Research
Barcelona, Spain
LeukemiaHematologyBlood CancersChronic Lymphocytic LeukemiaResearch Network
Website
Company

ErVimmune

ErVimmune develops cancer vaccines and T cell-based therapies as breakthrough immunotherapies to address unmet medical needs in cold tumors. We are dedicated to discovering more accurate non-mutated tumor epitopes that are shared across patients and indications. Supported by a proprietary, AI-driven target discovery platform, we focus on non-conventional antigens derived from human endogenous retroviruses (HERVs) as targets that we validate by proteomics and immunology assays. From bioinformatics to proteomics!

Cancer vaccines and T cell-based therapies targeting HERV-derived antigens, for Cancer Immunotherapy
Lyon, France
Drug Discovery & DevelopmentBiologicsCancer VaccinesCell TherapyT-cell TherapyHERVsHERV-Derived Antigens
Website
Professional Association

ESH

The European School of Haematology (ESH) is a not-for-profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Haematology.

Hematology; Cancer; Oncology
Paris, France
Website
Professional Association

ESID (European Society for Immunodeficiencies)

The European Society for immunodeficiencies (ESID) is a non for profit association that was created in 1994. ESID has been striving to improve the knowledge in the field of Primary Immunodeficiency (PID) by encouraging research, developing educational programs and fostering cooperation among all those involved in the diagnosis, treatment and management of these diseases. ESID is organized in 7 working parties – Inborn Errors, Clinical, Education, Genetics, Registry, ESID Juniors, PID Care in Development. ESID has invested in several activities such as: · ESID Biennial Congress; · ESID Summer School; · Endorsed activities; · Awards and Grants; · ESID Registry; and · ESID Guidelines

Immunodeficiency
Amsterdam, Netherlands
ImmunodeficiencyImmunologyHemato-OncologyBlood CancersCancer Treatment
Website
Professional Association

ESMO

The European Society for Medical Oncology's (ESMO) core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up. It is to educate – doctors, cancer patients and the general public – on the best practices and latest advances in oncology. And it is to promote equal access to optimal cancer care for all patients.

Lugano, Switzerland
Website
Professional Association

ESO

The European School of Oncology (ESO) is an independently funded non profit organisation dedicated to quality education and training, because we believe all patients deserve equal access to competent cancer care.

Bellinzona, Switzerland
Website
Patient Advocacy Group

Esperantra

In Spanish: "ESPERANTRA es una organización sin fines de lucro, fundada con el propósito de contribuir en la reducción de la mortalidad por cáncer, enfermedades raras y crónicas no transmisbles en el Perú y mejorar la calidad de vida de los pacientes, abogando por la igualdad de acceso a tratamientos de calidad y cuidados innovadores. Hasta el 2005 no existía ninguna organización que representara y catalizara las necesidades de los pacientes, por tal motivo se creo ESPERANTRA. Somos la primera organización a nivel nacional que proporciona información y ayuda a través de sus diversos programas orientados al bienestar de los pacientes de todas las edades y sus familiares. MISIÓN: Informar, educar y orientar a los pacientes, familiares y población en general para lograr un diagnostico oportuno mediante programas de prevención responsable y control de la enfermedad trabajando en conjunto con los tomadores de desiciones para mejorar la calidad de vida de los pacientes del Perú con estos diagnósticos."

San Isidro (Lima), Peru
Patient AdvocacyPatient CareEducationPublic HealthCancer ControlCancer CareEpidemiology
Website
University / R&D Center

ESPUM (École de santé publique)

The only French-language school in the world and the second in Canada to be accredited by the Council on Education for Public Health (CEPH), the School of Public Health of the Université de Montréal (ESPUM) is a centre of excellence and critical thinking in teaching, research and knowledge translation in all fields of public health. Drawing on knowledge derived from scientific excellence, the School offers recognized high-level training for undergraduate and graduate students.

Public Health
Montréal, QC, Canada
Public HealthHealthcare AccessEducationTrainingQuébecCanada
Website
Professional Association

ESTRO (European Society for Radiotherapy & Oncology)

ESTRO’s new vision statement for 2030 ‘Radiation Oncology. Optimal Health for All, Together.’ emphasizes the ambition of the Society to further reinforce radiation oncology as core partner in multidisciplinary cancer care and to guarantee accessible and high-value radiation therapy for all cancer patients who need it. To do so, it will actively focus on translating science and evidence into practice. It will continue to support all radiotherapy professionals in their needs of continuous professional development. The needs of a growing Society in terms of governance and leadership will actively be addressed. The Society will also increasingly embrace its role in policy, through a broadening network of partnerships with all relevant stakeholders. Without calling for a disruptive change with the past, but conscious of the challenges ahead, the ESTRO vision statement for 2030 is ambitious, expansive, inclusive and open to the future.

Radiation Oncology
Brussels, Belgium
Radiation OncologyOnco-RadiologyRadiation TherapySBRTRadiopharmaceuticalsRadioconjugatesRadiotherapy
Website
Other

EURACAN

EURACAN is a consortium of 102 European expert centres, European Patients Advocates (ePAGs) and relevant stakeholders whose goal is to improve access to care and clinical excellence for patients with Rare Adult Solid Cancers (RASCs) across the European Union and Ukraine.

Website